EUVIMEDEUVIMED entdecken
Crossref

Ex Vivo Zinc Nanoparticle Conditioning Primes T Cells for Potent Antitumor Activity in Ovarian Cancer Patient-Derived Xenografts

Zhangyun Gong, Kai Chen, Aoran Luo, Jie Zhang, Haixing Yi, Xiangyuan Xie, Kaixin Dai, Zhimin Lu, Yiran Xie iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Zhangyun Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Zinc, T-Lymphocytes, Metal Nanoparticles. Die Arbeit nennt 31 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Shanghai East Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T-cell dysfunction imposed by the tumor microenvironment limits the durability of cellular immunotherapies, motivating interventions that strengthen effector programs before infusion. Here we describe an ex vivo pretreatment that uses zinc nanoparticles (Zn NPs) as a transient intracellular Zn2+ modulator to condition T cells without altering receptor engineering. Brief priming with Zn NPs yielded T cells with consistently improved tumor-cell killing across effector-to-target ratios and increased IL-2, IFN-γ, and TNF-α secretion while avoiding rises in intracellular ROS. In murine melanoma models, adoptive transfer of primed T cells delayed tumor growth and prolonged survival without toxicity; combination with Galectin-9 blockade further enhanced control. Translational relevance was supported in an ovarian cancer patient-derived xenograft model, where primed CAR T cells achieved superior tumor control, showed greater intratumoral CAR T infiltration, and again benefited from Galectin-9 inhibition. Transcriptome profiling of primed T cells revealed coordinated remodeling of metal-ion response, consistent with reinforced signaling and stress resilience. This study establishes Zn NP-enabled priming as a practical, drop-in step for T-cell manufacturing that enhances effector function and cooperates with galectin-axis inhibition to overcome microenvironmental suppression and improve therapeutic potency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsZincT-LymphocytesMetal NanoparticlesFemaleAnimalsHumansMiceXenograft Model Antitumor AssaysCell Line, TumorTumor MicroenvironmentGalectinsImmunotherapy, Adoptive

Stichwörter der Autor:innen

CAR T cell therapyT-cell priminggalectin-9 blockadeovarian cancer patient-derived xenograftzinc nanoparticles

Substanzen

ZincGalectinsLGALS9 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education) and Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
  • Zhejiang Key Laboratory of Maternal and Infant Health, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
  • Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.

ORCID-Profile: Yiran Xie

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Shanghai East Hospital
  • Pujiang Project of Shanghai Magnolia Talent Program

Zitieren

APA

Gong, Z., Chen, K., Luo, A., Zhang, J., Yi, H., Xie, X., Dai, K., Lu, Z., & Xie, Y. (2026). Ex Vivo Zinc Nanoparticle Conditioning Primes T Cells for Potent Antitumor Activity in Ovarian Cancer Patient-Derived Xenografts. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01508

Vancouver

Gong Z, Chen K, Luo A, Zhang J, Yi H, Xie X, et al. Ex Vivo Zinc Nanoparticle Conditioning Primes T Cells for Potent Antitumor Activity in Ovarian Cancer Patient-Derived Xenografts. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01508

BibTeX
@article{Gong2026,
  author = {Gong, Zhangyun and Chen, Kai and Luo, Aoran and Zhang, Jie and Yi, Haixing and Xie, Xiangyuan and Dai, Kaixin and Lu, Zhimin and Xie, Yiran},
  title = {Ex Vivo Zinc Nanoparticle Conditioning Primes T Cells for Potent Antitumor Activity in Ovarian Cancer Patient-Derived Xenografts},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01508}
}
Kostenlos starten →